CRA-024781:: A potent histone deacetylase (HDAC) inhibitor with antitumor activity in vitro and in vivo

被引：0

作者：

Buggy, JJ ^{[1
]}

Cao, ZA ^{[1
]}

Bass, KE ^{[1
]}

Balasubramanian, S ^{[1
]}

Schultz, BE ^{[1
]}

Liu, LA ^{[1
]}

Leung, L ^{[1
]}

Davis, JR ^{[1
]}

Ngadimo, D ^{[1
]}

Misialek, S ^{[1
]}

Verner, E ^{[1
]}

Dalrymple, SA ^{[1
]}

Young, PR ^{[1
]}

机构：

[1] Celera Genom, San Francisco, CA USA

来源：

CLINICAL CANCER RESEARCH | 2005年 / 11卷 / 24期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：9081S / 9081S

页数：1

共 50 条

[1] CRA-024781:: a novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in vitro and in vivo
Buggy, Joseph J.
Cao, Z. Alexander
Bass, Kathryn E.
Verner, Erik
Balasubramanian, Sriram
Liu, Liang
Schultz, Brian E.
Young, Peter R.
Dalrymple, Stacie A.
MOLECULAR CANCER THERAPEUTICS, 2006, 5 (05) : 1309 - 1317
[2] CRA-026440:: a potent, broad-spectrum, hydroxamic histone deacetylase inhibitor with antiproliferative and antiangiogenic activity in vitro and in vivo
Cao, Z. Alexander
Bass, Kathryn E.
Balasubramanian, Sriram
Liu, Liang
Schultz, Brian
Verner, Erik
Dai, YuQin
Molina, Rafael A.
Davis, Jack R.
Misialek, Shawn
Sendzik, Martin
Orr, Christine J.
Leung, Ling
Callan, Ondine
Young, Peter
Dalrymple, Stacie A.
Buggy, Joseph J.
MOLECULAR CANCER THERAPEUTICS, 2006, 5 (07) : 1693 - 1701
[3] Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo
Vigushin, DM
Ali, S
Pace, PE
Mirsaidi, N
Ito, K
Adcock, I
Coombes, RC
CLINICAL CANCER RESEARCH, 2001, 7 (04) : 971 - 976
[4] CRA-026440, a potent histone deacetylase (HDAC) inhibitor, as an anti-cancer agent.
Cao, ZA
Bass, KE
Liu, LA
Balasubramanian, S
Verner, E
Schultz, BE
Molina, R
Leung, L
Sendzik, M
Davis, JR
Squires, N
Misialek, S
Orr, C
Buggy, JJ
Dalrymple, SA
CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9146S - 9146S
[5] Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo.
Vigushin, DM
Ali, S
Pace, P
Ito, K
Adcock, I
Coombes, RC
CLINICAL CANCER RESEARCH, 1999, 5 : 3777S - 3777S
[6] A novel series of potent and selective ketone histone deacetylase inhibitors with antitumor activity in vivo
Jones, Philip
Altamura, Sergio
De Francesco, Raffaele
Paz, Odalys Gonzalez
Kinzel, Olaf
Mesiti, Giuseppe
Monteagudo, Edith
Pescatore, Giovanna
Rowley, Michael
Verdirame, Maria
Steinkijhler, Christian
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (08) : 2350 - 2353
[7] Discovery of a Potent Class I Selective Ketone Histone Deacetylase Inhibitor with Antitumor Activity in Vivo and Optimized Pharmacokinetic Properties
Kinzel, Olaf
Llauger-Bufi, Laura
Pescatore, Giovanna
Rowley, Michael
Schultz-Fademrecht, Carsten
Monteagudo, Edith
Fonsi, Massimiliano
Paz, Odalys Gonzalez
Fiore, Fabrizio
Steinkuehler, Christian
Jones, Philip
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (11) : 3453 - 3456
[8] Evaluation of the In vitro and In vivo antitumor activity of histone deacetylase inhibitors for the therapy of retinoblastoma
Dalgard, Clifton Lee
Van Quill, Kurtis R.
O'Brien, Joan M.
CLINICAL CANCER RESEARCH, 2008, 14 (10) : 3113 - 3123
[9] Enhanced antitumor activity of combined methotrexate and histone deacetylase inhibitor valproic acid on mammary cancer in vitro and in vivo
El Said, Hadia H.
Badary, Osama A.
Shouman, Samia A.
Elmazar, Mohamed M.
El-Khatib, Aiman S.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2022, 100 (09) : 915 - 925
[10] Discovery of NVP-LAQ824, a novel histone deacetylase inhibitor with in vitro and in vivo antitumor activity.
Remiszewski, SW
Sambucetti, LC
Atadja, P
Bair, KW
Bontempo, J
Cesarz, D
Chandramouli, N
Chen, R
Dean, K
Diamantidis, G
Green, MA
Howell, KL
Kashi, R
Kwon, P
Lassota, P
Mou, Y
Nemzek, R
Perez, LB
Sorensen, E
Taplin, F
Trogani, N
Versace, R
Walker, H
Weltchek-Engler, S
Wood, AW
Wu, A
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U46 - U46

← 1 2 3 4 5 →